PubMed COVID-19 Clinical Care

CONCLUSION: Participants developed their own understanding of COVID-19 risk perception through personal experience and comparison with others around them, irrespective of vulnerability status. COVID-19 guidance was not complied with as intended by

CONCLUSION: SAT secondary to COVID-19 seems to manifest almost similarly to the conventional SAT. However, except for the case reports and case series, lack of studies has limited the quality of the data at hand.

CONCLUSION: RBD peptide exposure has different effects depending on the cell line, exposure time, and concentration. This study brings new evidence about the immunogenic profile of RBD in macrophage and microglial cells, advancing the understanding

Automatic generation of medical reports can provide diagnostic assistance to doctors and reduce their workload. To improve the quality of the generated medical reports, injecting auxiliary information through knowledge graphs or templates into the

The nucleocapsid (N-)protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a key role in viral assembly and scaffolding of the viral RNA. It promotes liquid-liquid phase separation (LLPS), forming dense droplets that support the

Stigma remains a significant problem globally, creating barriers to services for individuals in need, regardless of access to services. The stigma of COVID-19 primarily happened because it is a new disease with several unknowns, and these unknowns

[This corrects the article DOI: 10.1371/journal.pgph.0000561.].

The COVID-19 virus has affected many people around the globe with several issues. Moreover, it causes a worldwide pandemic, and it makes more than one million deaths. Countries around the globe had to announce a complete lockdown when the corona

With the onset of the COVID-19 pandemic, telehealth became a widely used method to provide patient care. Providers had to quickly learn how to adapt traditional clinical care to the virtual environment. The existing literature focuses on the

CONTEXT: The unavailability of target-specific antiviral drugs for SARS-CoV-2 viral infection kindled the motivation to virtually design derivatives of 6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide as potential antiviral inhibitors against the